Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8744271 | Acta Tropica | 2018 | 5 Pages |
Abstract
We performed a literature search to delineate the contemporary evidence for the use of liposomal amphotericin B, and found that although cure rates of 17/20 (85%) were achieved in immune competent patients with Old World cutaneous leishmaniasis and cure rates of 10/13 (77%) for Old World mucosal leishmaniasis due to L. infantum, the available data is highly limited with high variation in total treatment dosages. The presented findings reflect a lack of consensus on the optimal treatment dosage and on the schedule of application.
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
Vincent Mosimann, Andreas Neumayr, Daniel H. Paris, Johannes Blum,